Vendula Hepnarova
Hradec Kralove, KR 50001, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoning.
Journal: Archives of toxicology
Published: October 29, 2025
A-series agent A-234: initial in vitro and in vivo characterization.
Journal: Archives of toxicology
Published: January 05, 2024
Uncharged mono- and bisoximes: In search of a zwitterion to countermeasure organophosphorus intoxication.
Journal: Chemico-biological interactions
Published: January 02, 2024
A-agents, misleadingly known as "Novichoks": a narrative review.
Journal: Archives of toxicology
Published: July 11, 2023
Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 08, 2023
Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: June 13, 2022
A Comparison of the Neuroprotective and Reactivating Efficacy of a Novel Bispyridinium Oxime K870 with Commonly Used Pralidoxime and the Oxime HI-6 in Tabun-Poisoned Rats.
Journal: Acta medica (Hradec Kralove)
Published: November 15, 2021
Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K870.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: September 07, 2021
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 14, 2021
Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease.
Journal: Future medicinal chemistry
Published: April 08, 2021
(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 02, 2021
Huprine Y - Tryptophan heterodimers with potential implication to Alzheimer's disease treatment.
Journal: Bioorganic & medicinal chemistry letters
Published: February 12, 2021
Last Updated: 09/26/2026